AMPH: Amphastar Pharmaceuticals, Inc. Stock

by  •  • Comments Off on AMPH: Amphastar Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,889.16
Enterprise Value ($M) 2,334.88
Book Value ($M) 639.42
Book Value / Share 13.09
Price / Book 2.95
NCAV ($M) -383.89
NCAV / Share -7.86
Price / NCAV -4.92

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.18
Return on Equity (ROE) 0.25

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 2.17

Balance Sheet (mrq) ($M)
Current Assets 489.60
Assets 1,512.91
Liabilities 873.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 644.39
Operating Income 202.34
Net Income 137.54
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 183.50
Cash from Investing -649.12
Cash from Financing 454.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-06 13G/A Federated Hermes, Inc. 4.52 -33.85
02-13 13G/A Vanguard Group Inc 5.88 7.36
02-09 13G/A Zhang Jack Y. 26.20 2.48
01-23 13G/A BlackRock Inc. 12.60 -14.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 37,589 263,491 14.27
2024-04-17 116,372 494,599 23.53
2024-04-16 46,913 305,212 15.37
2024-04-15 110,950 403,717 27.48

(click for more detail)

Similar Companies
ALXO – ALX Oncology Holdings Inc. AMGN – Amgen Inc.
AMLX – Amylyx Pharmaceuticals, Inc. AMRX – Amneal Pharmaceuticals, Inc.
ANAB – AnaptysBio, Inc.


Financial data and stock pages provided by
Fintel.io